Trial intelligence / Profile preview

Immediate vs Delayed Radiotherapy With Triptorelin in Prostate Cancer

NCT00667069Phase 3Completed

Sponsor
Unicancer
Start
Apr 2008
Primary completion
Apr 2020
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of triptorelin in prostate cancer (PCa), sponsored by Unicancer. Started Apr 2008; status: completed.

02

Drugs

triptorelin
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00667069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00667069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call